GSN and pancreatic neoplasm: Downregulation of gelsolin protein expression in most malignancies is attributes to gene inactivation mediated by epigenetic modifications or impairment of promoter activity regulated by activating transcription factors or by ubiquitin-proteasomal degradation, as reported in pancreatic cancer [34,35,36].